Evidence map›Paper›PMID 32655366›Full record

ArticleFrontiers in molecular neuroscience2020

Effects of ASC Application on Endplate Regeneration Upon Glycerol-Induced Muscle Damage.

Matteo Rigon, Sarah Janice Hörner, Tatjana Straka, Karen Bieback, Norbert Gretz, Mathias Hafner, Rüdiger Rudolf

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Matteo RigonInstitute of Molecular and Cell Biology, Mannheim University of Applied Sciences, Mannheim, Germany.
Sarah Janice HörnerInstitute of Molecular and Cell Biology, Mannheim University of Applied Sciences, Mannheim, Germany.
Tatjana StrakaInstitute of Molecular and Cell Biology, Mannheim University of Applied Sciences, Mannheim, Germany.
Karen BiebackInstitute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Norbert GretzMedical Research Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Mathias HafnerInstitute of Molecular and Cell Biology, Mannheim University of Applied Sciences, Mannheim, Germany.
Rüdiger RudolfInstitute of Molecular and Cell Biology, Mannheim University of Applied Sciences, Mannheim, Germany.
Heidelberg University · DEMannheim University of Applied Sciences · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amongst other approaches, adipose-derived stromal cells (ASCs) have recently been tested with respect to their regenerative capacity for treatment of neuromuscular disorders. While beneficial effects of ASCs on muscle recovery were observed previously, their impact on regeneration of neuromuscular junctions (NMJs) is unclear. Here, we used a murine glycerol damage model to study disruption and regeneration of NMJs and to evaluate the effects of systemic application of ASCs on muscle and NMJ recovery. In mice that were not treated with ASCs, a differential response of NMJ pre- and post-synapses to glycerol-induced damage was observed. While post-synapses were still present in regions that were necrotic and lacking actin and dystrophin, pre-synapses disappeared soon in those affected areas. Partial regeneration of NMJs occurred within 11 days after damage. ASC treatment slightly enhanced NMJ recovery and reduced the loss of presynaptic sites, but also led to a late phase of muscle necrosis and fibrosis. In summary, the results suggest a differential sensitivity of NMJ pre- and post-synapses to glycerol-induced muscle damage and that the use of ASC for the treatment of neuromuscular disorders needs further careful evaluation.

Indexed as

ASCglycerolNMJregenerationskeletal muscle

Identifiers

PMID32655366
PMCPMC7324987
OpenAlexW3036716067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.